The clinical efficacy and safety of biologic agents for moderate to severe atopic dermatitis: a meta-analysis

被引：0
|
作者：
Peng, G. [1 ,2 ,3 ]
Li, L. [3 ]
Han, X. [3 ]
机构：
[1] Juntendo Univ, Dermatol, Tokyo, Japan
[2] Juntendo Univ, Atop Res Ctr, Tokyo, Japan
[3] China Med Univ, Shengjing Hosp, Dermatol, Shenyang, Liaoning, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 09期
关键词：
D O I：
10.1016/j.jid.2019.07.144
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
140
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
    Meher, Bikash R.
    Mishra, Archana
    Behera, Biswanath
    Ponnusamy, Subashri
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [2] Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Meher, Bikash Ranjan
    Mohanty, Rashmi Ranjan
    Padhy, Biswa Mohan
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2335 - 2343
  • [3] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Zeng, Linxi
    Feng, Sen
    Yao, Lulu
    Wang, Bin
    Zhang, Guoqiang
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 734 - 740
  • [4] Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis
    Li, Ling
    Yu, Jiajun
    Chen, Baoqing
    Guo, Ying
    Yang, Yufeng
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [5] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
    Huang, Yuanjie
    Cai, Limin
    Wu, Xuerui
    Chen, Chen
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 725 - 733
  • [6] The efficacy and safety of lebrikizumab monotherapy for the management of moderate to severe atopic dermatitis: A systematic review and meta-analysis
    Bashrahil, B.
    Alzahrani, Z.
    Aman, A.
    Samarkandy, S.
    Jfri, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S106 - S106
  • [7] Network meta-analysis on the efficacy and safety of upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis
    Qiu, Mei
    Duan, Xue-Yan
    Yin, Dao-Gen
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (01) : E24 - E26
  • [8] Efficacy and safety of baricitinib for the treatment of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis of randomized clinical trials
    Wang, Bin
    Pan, Shuaixi
    Yao, Yue
    Zeng, Linxi
    Zhang, Guoqiang
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (11) : 1139 - 1149
  • [9] The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Bashrahil, Bader
    Alzahrani, Ziyad
    Samarkandy, Sahal
    Aman, Abdullah
    Jfri, Abdulhadi
    [J]. FRONTIERS IN MEDICINE, 2023, 9
  • [10] Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized controlled trials
    Wu, Shuying
    Wang, Huiping
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (03): : 601 - 610
12345